Oregon 2022 Regular Session Status: In Committee Bipartisan · 7 D · 1 R cosponsors

HB 4081 — Relating to naloxone; prescribing an effective date.

Last action — In committee upon adjournment.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Requires pharmacist who dispenses opioid prescription to offer prescription for naloxone, or similar drug, and information about naloxone under specified circumstances. Creates exceptions to requirement to offer prescription for naloxone or similar drug. <b>Allows pharmacy, health care professional or pharmacist to distribute and administer drug similar to naloxone. Allows certain persons to administer, to individual experiencing opioid overdose, drug similar to naloxone that was not distributed to individual. Requires pharmacies to provide written notice that drug similar to naloxone is available at pharmacy.</b> Requires health benefit plan to provide payment or reimbursement for naloxone prescription and dispensation by pharmacist. Becomes operative January 1, 2023. Takes effect on 91st day following adjournment sine die.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 4081 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Referred to Ways and Means by order of Speaker.

  3. Recommendation: Do pass with amendments, be printed A-Engrossed, and be referred to Ways and Means.

  4. Work Session held.

  5. Public Hearing held.

  6. Referred to Health Care.

  7. First reading. Referred to Speaker's desk.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 17 co-sponsors · 71 not signed on · 3 voted No

Sponsors (2)

Co-sponsors (17)

Not signed on (71)

71 members have not signed on to this bill.

Show all 71 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Heard and Reported Out with Amendments

Passed 7 Yea · 3 Nay
Party YeaNayPresentNot Voting
Unaffiliated 5200
Democrat 1000
Republican 1100
Total 7300
% of votes cast 70%30%0%0%
How each member voted (10)
Member Party Vote
Andrea Salinas — Yea
Maxine Dexter — Yea
Rachel Prusak — Yea
Raquel Moore-Green — Nay
Ron Noble — Nay
Sheri Schouten — Yea
Teresa Alonso Leon — Yea
Wlnsvey Campos Democrat Yea
Cedric Hayden Republican Nay
Suzanne Weber Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 4081 do?
Requires pharmacist who dispenses opioid prescription to offer prescription for naloxone, or similar drug, and information about naloxone under specified circumstances. Creates exceptions to requirement to offer prescription for naloxone or similar drug. <b>Allows pharmacy, health care professional or pharmacist to distribute and administer drug similar to naloxone. Allows certain persons to administer, to individual experiencing opioid overdose, drug similar to naloxone that was not distributed to individual. Requires pharmacies to provide written notice that drug similar to naloxone is available at pharmacy.</b> Requires health benefit plan to provide payment or reimbursement for naloxone prescription and dispensation by pharmacist. Becomes operative January 1, 2023. Takes effect on 91st day following adjournment sine die.
Who sponsors HB 4081?
HB 4081 is sponsored by Rob Nosse (Democrat), Khanh Pham (Democrat), Suzanne Weber (Republican), Wlnsvey Campos (Democrat), Elizabeth Steiner, Chris Gorsek (Democrat), Jeff Golden (Democrat), Pam Marsh (Democrat), Dacia Grayber (Democrat), Rachel Prusak, Bill Kennemer, Maxine Dexter, Courtney Neron, Lisa Reynolds, Sheri Schouten, Barbara Smith Warner, Anna Williams, Chris Hoy, and Teresa Alonso Leon.
What is the current status of HB 4081?
This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 4081?
Track HB 4081 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 4081

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 4081

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →